Previous 10 | Next 10 |
Nautilus Biotechnology, Inc. (NAUT) Q1 2022 Earnings Conference Call May 3, 2022 8:30 a.m. ET Company Participants Sujal Patel - Co-Founder & CEO Anna Mowry - CFO Parag Mallick - Co-Founder & Chief Scientific Officer Conference Call Participants Matt Kim - Jefferies Stephanie Yan - Co...
Nautilus Biotechnology press release (NASDAQ:NAUT): Q1 Non-GAAP EPS of -$0.13 beats by $0.03. Cash, cash equivalents, and investments were $349.0 million as of March 31, 2022. For further details see: Nautilus Biotechnology Non-GAAP EPS of -$0.13 beats by $0.03
SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights S...
Nautilus Biotechnology (NASDAQ:NAUT) is scheduled to announce Q1 earnings results on Tuesday, May 3rd, before market open. The consensus EPS Estimate is -$0.16 and the consensus Revenue Estimate is $0.17M Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. For ...
ACRE,AGCO,AHH,AME,AQUA,ARNC,ATKR,BEN,BIIB,OTCQX:BNPQF,BP,BPMC,BR,BRSP,CEIX,CMI,CMS,CNHI,CNP,CTLT,CVLT,CZOO,DD,DEA,DK,DKL,OTCPK:DPSTF,DSKE,EL,ESPR,ETN,ETRN,EXPD,FIS,OTCQB:FNMA,GEO,GLDD,HLT,HSIC,HWM,INCY,IPGP,IT,ITT,ITW,J,KKR,KOPN,LDOS,LEA,LGIH,LODE,LPX,MLM,MPC,MPLX,MTOR,NAUT,OTCQX:NHYDY,NNN,NR...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com Moving stocks this morning is drug trial news, recent e...
SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointments of Gwen Weld as Chief People Officer and Sher...
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the first quarter 20...
• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate Director Greg Kapp, Ph.D., to present poster at American Association for Cancer Research (AACR) Annual Meeting S...
SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Karen Akinsanya, Ph.D., to its Board of Dir...
News, Short Squeeze, Breakout and More Instantly...
Nautilus Biotechnology Inc. Company Name:
NAUT Stock Symbol:
NASDAQ Market:
Nautilus Biotechnology Inc. Website:
SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the second quarter 2024 before market open on Tuesday, July 3...
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference. Nauti...
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2024. “We continued to ...